US vaccine maker to establish research and production facilities

Published: 2007-07-12 06:57:00

Updated: 2007-07-12 06:57:00

VGX Pharmaceutical Inc., a U.S pharmaceutical company, will invest $200 million in building its Asian regional headquarters in Korea, according to the Ministry of Health and Welfare on July 9.

VGX is a leading biopharmaceutical company with strong product candidates for the treatment of infectious diseases including HIV and hepatitis C virus (HCV) as well as cancer and inflammatory diseases....

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.